Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

Fudan University · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
nasmallcelllungcancer
small cell lung cancer recurrent, small cell lung cancer, liposomal irinotecan, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 825406
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.